Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. New research highlights the effectiveness of targeted therapies for ...

NVDA is a Strong Buy with 34% upside as AI chip demand surges, earnings rise, and China H200 approval nears—get the latest ...

Since 2022, the seventh cholera pandemic has escalated globally, with reported cases rising from 223 370 in 2021 to 560 823 in 2024 across affected countries. Cholera-related deaths also increased ...

Background Aortic valve calcification (AVC) is a disease process driven by inflammation and lipid infiltration, serving as a ...

Security teams often spend days manually turning long incident reports and threat writeups into actionable detections by ...

Probius to develop AI-powered point-of-care screening technology, eliminating sample preparation requirements and ...

TIME, in partnership with Statista R, the leading global provider of market and consumer data and rankings, has published the ...

From historic AI spendings to ambitious 6G roadmaps, test and measurement players have their eyes set on some of the biggest ...

Influence of Elephant-Driven Vegetation Structure and Altitudinal Gradient on the Occurrence of the Endemic Mount Cameroon Francolin ...

Sufficient power is a hurdle to Pentagon aspirations for AI in combat. A panel at the 2026 Defense R&D Summit will examine this issue.

In at least 19 incidents, federal immigration officers have fired guns at civilians under President Trump's immigration ...